๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

DECREASED SERUM ADIPONECTIN LEVELS IN PATIENTS WITH RENAL CELL CARCINOMA

โœ Scribed by Horiguchi, Akio; Ito, Keiichi; Sumitomo, Makoto; Kimura, Fumihiro; Asano, Tomohiko; Hayakawa, Masamichi

Book ID
123413542
Publisher
Lippincott Williams and Wilkins
Year
2008
Tongue
English
Weight
147 KB
Volume
179
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Serum beta 2 microglobulin levels in pat
Serum beta 2 microglobulin levels in patients with renal cell carcinoma
โœ Selli, C. ;Cozzolino, F. ;Carini, M. ;Lenzi, R. ;Vercelli, D. ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 229 KB

Serum B2m concentrations were evaluated preoperatively in 40 patients with renal cell carcinoma and normal renal function, as assessed by serum creatinine less than 1.4 mg/dl, and compared with those of 23 age-matched controls. Mean value +/- SD was 3,088 +/- 966 ng/ml for renal cancer patients, whi

Elevated levels of serum aldolase A in p
Elevated levels of serum aldolase A in patients with renal cell carcinoma
โœ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha